Legal & General Group Plc Buys 45,189 Shares of Core Scientific, Inc. (NASDAQ:CORZ)

Legal & General Group Plc boosted its holdings in shares of Core Scientific, Inc. (NASDAQ:CORZ - Free Report) by 30.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 194,368 shares of the company's stock after acquiring an additional 45,189 shares during the period. Legal & General Group Plc owned approximately 0.07% of Core Scientific worth $2,731,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Sanctuary Advisors LLC boosted its position in Core Scientific by 130.1% during the 3rd quarter. Sanctuary Advisors LLC now owns 34,527 shares of the company's stock worth $409,000 after acquiring an additional 19,522 shares during the last quarter. JPMorgan Chase & Co. raised its stake in Core Scientific by 48.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 437,812 shares of the company's stock valued at $5,192,000 after acquiring an additional 142,068 shares during the period. Wealth Enhancement Advisory Services LLC raised its stake in Core Scientific by 25.6% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 98,077 shares of the company's stock valued at $1,378,000 after acquiring an additional 20,000 shares during the period. ORG Wealth Partners LLC increased its position in Core Scientific by 0.3% during the 4th quarter. ORG Wealth Partners LLC now owns 8,986,651 shares of the company's stock worth $126,262,000 after buying an additional 26,649 shares during the period. Finally, FNY Investment Advisers LLC increased its position in Core Scientific by 35.8% during the 4th quarter. FNY Investment Advisers LLC now owns 190,747 shares of the company's stock worth $2,679,000 after buying an additional 50,275 shares during the period.

Insider Buying and Selling

In related news, Director Todd A. Becker sold 134,250 shares of the stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $10.75, for a total transaction of $1,443,187.50. Following the sale, the director now directly owns 195,687 shares of the company's stock, valued at $2,103,635.25. This trade represents a 40.69 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Jordan Levy acquired 62,500 shares of the company's stock in a transaction that occurred on Thursday, March 6th. The shares were acquired at an average cost of $8.01 per share, for a total transaction of $500,625.00. Following the completion of the transaction, the director now directly owns 306,887 shares of the company's stock, valued at $2,458,164.87. The trade was a 25.57 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 1.40% of the stock is currently owned by corporate insiders.

Core Scientific Stock Performance

Shares of Core Scientific stock traded down $0.26 during trading hours on Tuesday, reaching $7.98. The company's stock had a trading volume of 859,178 shares, compared to its average volume of 12,632,172. Core Scientific, Inc. has a one year low of $2.88 and a one year high of $18.63. The company has a market capitalization of $2.35 billion, a P/E ratio of -1.47 and a beta of 6.80. The stock's fifty day simple moving average is $8.22 and its two-hundred day simple moving average is $12.34.

Core Scientific (NASDAQ:CORZ - Get Free Report) last announced its earnings results on Wednesday, February 26th. The company reported ($0.01) EPS for the quarter, beating the consensus estimate of ($0.10) by $0.09. The firm had revenue of $94.93 million during the quarter, compared to analysts' expectations of $97.07 million. As a group, research analysts forecast that Core Scientific, Inc. will post 0.52 earnings per share for the current year.

Analyst Ratings Changes

CORZ has been the topic of a number of recent analyst reports. Cantor Fitzgerald decreased their price target on Core Scientific from $24.00 to $21.00 and set an "overweight" rating on the stock in a research report on Thursday, February 27th. Needham & Company LLC reduced their price objective on Core Scientific from $18.00 to $17.00 and set a "buy" rating on the stock in a research note on Thursday, February 27th. Canaccord Genuity Group reaffirmed a "buy" rating and issued a $17.00 price objective on shares of Core Scientific in a research note on Wednesday, March 12th. Compass Point decreased their price target on shares of Core Scientific from $26.00 to $20.00 and set a "buy" rating for the company in a research report on Tuesday, February 25th. Finally, Craig Hallum initiated coverage on shares of Core Scientific in a research report on Tuesday, January 21st. They issued a "buy" rating and a $24.00 price target for the company. Fifteen investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, Core Scientific presently has an average rating of "Buy" and an average target price of $19.07.

Core Scientific Company Profile

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.